v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2026
Apr. 30, 2026
Current assets:    
Cash and cash equivalents $ 7,356 $ 8,719
Restricted cash, short-term 154 154
Accounts receivable, net 1,249 587
Contract assets 269 590
Inventory 4,552 3,190
Other current assets 1,852 2,648
Total current assets 15,432 15,888
Property and equipment, net 9,798 10,255
Intangibles, net 3,324 3,357
Right-of-use assets, net 1,614 1,886
Goodwill 8,537 8,537
Total assets 38,705 39,923
Current liabilities:    
Accounts payable 6,726 4,366
Earn out payable 50 150
Convertible notes payable (Note 13) 8,068 10,428
Warrant liability 3,756
Accrued expenses 4,608 4,232
Contract liabilities, current 5,091 6,029
Right-of-use liabilities, current portion 1,228 1,202
Total current liabilities 29,527 26,407
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 522 837
Total liabilities 30,252 27,447
Commitments and contingencies (Note 14)
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 400,000,000 shares, issued 9,094,159 shares and 7,704,867 shares, respectively; outstanding 9,004,628 shares and 7,615,336 shares, respectively 273 231
Treasury stock, at cost; 89,531 and 89,531 shares, respectively (1,825) (1,825)
Additional paid-in capital 401,503 395,031
Accumulated deficit (391,498) (380,961)
Accumulated other comprehensive loss
Total shareholders’ equity 8,453 12,476
Total liabilities and shareholders’ equity $ 38,705 $ 39,923